Brian Windle, MD

Brian Windle, MD

Certified by the American Board of Plastic Surgery as well as the Royal College of Physicians and Surgeons of Canada. Previously, he served as Acting Director of Plastic Surgery at University Hospitals of Cleveland, OH and was an Assistant Professor in the Department of Surgery at Case Western Reserve University for 10 years. Dr. Windle obtained his undergraduate degree from the University of Alberta (Canada) and his Doctor of Medicine degree from the University of Calgary. He completed his internship at Dalhousie University in Halifax, Nova Scotia and then did a surgical and plastic surgery residency at the University of Western Ontario Schulich School of Medicine in London, Ontario. He went on to do further, more specialized training in plastic surgery and cosmetic surgery at the University of Alabama Birmingham followed by facial plastic surgery and craniofacial plastic surgery training at Eastern Virginia Graduate School of Medicine in Norfolk, VA.

Facial cosmetic and reconstructive surgery along with breast surgery have been Dr. Windle’s areas of special interest for years. Over the last decade he has also developed a keen interest in Botox® and dermal fillers. He was the first to inject Artefill®, now known as Bellafill® in the Pacific Northwest. His vast experience and specialized techniques in this area led him to the realization that he could help a lot of people with these skills and he now focuses on these areas of plastic surgery in Kirkland, Bellevue and Seattle, WA.

He is a Fellow of the American College of Surgeons and a member of the American Society of Aesthetic Plastic Surgeons, the American Society of Plastic Surgeons as well as other regional and Canadian specialty organizations. His work has been published in the Annals of Plastic Surgery, Plastic and Reconstructive Surgery, the Journal of Reconstructive Microsurgery as well as other professional publications.

Dr. Windle has been a team leader in the Operation Smile Program since 1988, performing free reconstructive surgery on disadvantaged children around the world.

Brian Windle, MD
1700 116th Ave NE #100
Bellevue WA 98004
United States

Important Safety Information

Bellafill® is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years. Patients who have had a positive reaction to the Bellafill® Skin Test, have a history of severe allergies, have known bovine collagen allergies, are allergic to lidocaine, have bleeding disorders or are prone to thick scar formation and/or excessive scarring should not receive Bellafill®. The safety of Bellafill® for use during pregnancy, breastfeeding, or in patients under 21 has not been established. You may experience temporary swelling, redness, pain, bruising, lumps/bumps, itching, and discoloration at the treatment site. These side effects are usually transient and typically resolve within 1–7 days. You may experience lumps/bumps/papules that may occur more than one month after injection and that may persist. Less common side effects include rash and itching more than 48 hours after treatment, persistent swelling or redness, lumps/bumps, acne, and increased sensitivity at treatment sites. Infrequently, granulomas may occur and may be treated by your licensed physician provider. Be sure to call your licensed provider immediately if you notice any unusual skin reactions around the treatment area. Based on the 5-year Post-Approval Study on nasolabial folds with 1,008 patients, long-term safety of Bellafill® for up to 5 years has been established.

This product is certified as a medical device in the European Union under the Medical Device Directive 93/42/EEC by SGS CE0120, exclusively for the indication of autologous fat transfer. Other non-medical uses ascribed to this device such as aesthetic body contouring are not within the scope of CE certification, and users should be aware product performance and/or safety has not been evaluated by SGS for those purposes.

Suneva Medical HD PRP
REGULATORY STATUS: FDA-cleared 510(k) Class II medical device. Healeon HD PRP is designed to be used for the safe and rapid preparation of autologous platelet-rich-plasma (PRP) from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/orallograft bone prior to application to a bony defect for improving handling characteristics. 510(k) number: BK170136

Silhouette Instalift
Silhouette lnstaLift® is indicated for use in mid-face suspension surgery to temporarily fixate the cheek sub-dermis in an elevated position.

The Silhouette InstaLift device should not be used in patients with any known allergy or foreign body sensitivities to plastic/ biomaterial or in situations where internal fixation is otherwise contraindicated, (e.g. infection.) The device should also not be used in patients appearing to have very thin soft tissue of the face in which the implant may be visible or palpable.

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction, pain (which may be temporary or persistent in nature), swelling and edema, transient hematoma or bruising and transient rippling or dimple formation. For further safety or product information, please consult your physician.

For more safety information, please consult with your physician and the patient labeling that can be found by visiting our website
Toll-free call (U.S. & Canada): 844-Bellafill (844-235-5234).
Local calls: 858-550-9999. International calls: ++ 858-550-9999.